Literature DB >> 25489992

In vitro synthesis of modified mRNA for induction of protein expression in human cells.

Meltem Avci-Adali1, Andreas Behring2, Heidrun Steinle2, Timea Keller2, Stefanie Krajeweski2, Christian Schlensak2, Hans P Wendel2.   

Abstract

The exogenous delivery of coding synthetic messenger RNA (mRNA) for induction of protein synthesis in desired cells has enormous potential in the fields of regenerative medicine, basic cell biology, treatment of diseases, and reprogramming of cells. Here, we describe a step by step protocol for generation of modified mRNA with reduced immune activation potential and increased stability, quality control of produced mRNA, transfection of cells with mRNA and verification of the induced protein expression by flow cytometry. Up to 3 days after a single transfection with eGFP mRNA, the transfected HEK293 cells produce eGFP. In this video article, the synthesis of eGFP mRNA is described as an example. However, the procedure can be applied for production of other desired mRNA. Using the synthetic modified mRNA, cells can be induced to transiently express the desired proteins, which they normally would not express.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25489992      PMCID: PMC4354090          DOI: 10.3791/51943

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  14 in total

1.  Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability.

Authors:  Katalin Karikó; Hiromi Muramatsu; Frank A Welsh; János Ludwig; Hiroki Kato; Shizuo Akira; Drew Weissman
Journal:  Mol Ther       Date:  2008-09-16       Impact factor: 11.454

2.  Cystic fibrosis transmembrane conductance regulator-mRNA delivery: a novel alternative for cystic fibrosis gene therapy.

Authors:  Nadine Bangel-Ruland; Katja Tomczak; Elena Fernández Fernández; Geraldine Leier; Barbara Leciejewski; Carsten Rudolph; Joseph Rosenecker; Wolf-Michael Weber
Journal:  J Gene Med       Date:  2013 Nov-Dec       Impact factor: 4.565

3.  Expression of therapeutic proteins after delivery of chemically modified mRNA in mice.

Authors:  Michael S D Kormann; Günther Hasenpusch; Manish K Aneja; Gabriela Nica; Andreas W Flemmer; Susanne Herber-Jonat; Marceline Huppmann; Lauren E Mays; Marta Illenyi; Andrea Schams; Matthias Griese; Iris Bittmann; Rupert Handgretinger; Dominik Hartl; Joseph Rosenecker; Carsten Rudolph
Journal:  Nat Biotechnol       Date:  2011-01-09       Impact factor: 54.908

4.  Reprogramming human fibroblasts to pluripotency using modified mRNA.

Authors:  Pankaj K Mandal; Derrick J Rossi
Journal:  Nat Protoc       Date:  2013-02-21       Impact factor: 13.491

5.  Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection.

Authors:  Benjamin Petsch; Margit Schnee; Annette B Vogel; Elke Lange; Bernd Hoffmann; Daniel Voss; Thomas Schlake; Andreas Thess; Karl-Josef Kallen; Lothar Stitz; Thomas Kramps
Journal:  Nat Biotechnol       Date:  2012-11-25       Impact factor: 54.908

6.  Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1.

Authors:  Salima Hacein-Bey-Abina; Alexandrine Garrigue; Gary P Wang; Jean Soulier; Annick Lim; Estelle Morillon; Emmanuelle Clappier; Laure Caccavelli; Eric Delabesse; Kheira Beldjord; Vahid Asnafi; Elizabeth MacIntyre; Liliane Dal Cortivo; Isabelle Radford; Nicole Brousse; François Sigaux; Despina Moshous; Julia Hauer; Arndt Borkhardt; Bernd H Belohradsky; Uwe Wintergerst; Maria C Velez; Lily Leiva; Ricardo Sorensen; Nicolas Wulffraat; Stéphane Blanche; Frederic D Bushman; Alain Fischer; Marina Cavazzana-Calvo
Journal:  J Clin Invest       Date:  2008-09       Impact factor: 14.808

Review 7.  Naturally occurring nucleoside modifications suppress the immunostimulatory activity of RNA: implication for therapeutic RNA development.

Authors:  Katalin Karikó; Drew Weissman
Journal:  Curr Opin Drug Discov Devel       Date:  2007-09

8.  Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA.

Authors:  Luigi Warren; Philip D Manos; Tim Ahfeldt; Yuin-Han Loh; Hu Li; Frank Lau; Wataru Ebina; Pankaj K Mandal; Zachary D Smith; Alexander Meissner; George Q Daley; Andrew S Brack; James J Collins; Chad Cowan; Thorsten M Schlaeger; Derrick J Rossi
Journal:  Cell Stem Cell       Date:  2010-09-30       Impact factor: 24.633

9.  Design of an Optimized Wilms' Tumor 1 (WT1) mRNA Construct for Enhanced WT1 Expression and Improved Immunogenicity In Vitro and In Vivo.

Authors:  Daphné Benteyn; Sébastien Anguille; Sandra Van Lint; Carlo Heirman; An Mt Van Nuffel; Jurgen Corthals; Sebastian Ochsenreither; Wim Waelput; Katrien Van Beneden; Karine Breckpot; Viggo Van Tendeloo; Kris Thielemans; Aude Bonehill
Journal:  Mol Ther Nucleic Acids       Date:  2013-11-19       Impact factor: 10.183

10.  Optimized conditions for successful transfection of human endothelial cells with in vitro synthesized and modified mRNA for induction of protein expression.

Authors:  Meltem Avci-Adali; Andreas Behring; Timea Keller; Stefanie Krajewski; Christian Schlensak; Hans Peter Wendel
Journal:  J Biol Eng       Date:  2014-03-03       Impact factor: 4.355

View more
  15 in total

1.  RNA-based Reprogramming of Human Primary Fibroblasts into Induced Pluripotent Stem Cells.

Authors:  Patrick S McGrath; Nicole Diette; Igor Kogut; Ganna Bilousova
Journal:  J Vis Exp       Date:  2018-11-26       Impact factor: 1.355

2.  V-Maf Musculoaponeurotic Fibrosarcoma Oncogene Homolog A Synthetic Modified mRNA Drives Reprogramming of Human Pancreatic Duct-Derived Cells Into Insulin-Secreting Cells.

Authors:  Elisa Corritore; Yong-Syu Lee; Valentina Pasquale; Daniela Liberati; Mei-Ju Hsu; Catherine Anne Lombard; Patrick Van Der Smissen; Amedeo Vetere; Susan Bonner-Weir; Lorenzo Piemonti; Etienne Sokal; Philippe A Lysy
Journal:  Stem Cells Transl Med       Date:  2016-07-12       Impact factor: 6.940

3.  Light-Activated Control of Translation by Enzymatic Covalent mRNA Labeling.

Authors:  Dongyang Zhang; Cun Yu Zhou; Kayla N Busby; Seth C Alexander; Neal K Devaraj
Journal:  Angew Chem Int Ed Engl       Date:  2018-02-14       Impact factor: 15.336

4.  Selection and Validation of Reference Genes for RT-PCR Expression Analysis of Candidate Genes Involved in Morphine-Induced Conditioned Place Preference Mice.

Authors:  Qian Zhang; Mengting Zhang; Jiaqi Li; Hai Xiao; Dong Wu; Qiannan Guo; Yuwei Zhang; Hongdan Wang; Shengbin Li; Shixiu Liao
Journal:  J Mol Neurosci       Date:  2018-11-01       Impact factor: 3.444

5.  Cationic Nanoliposomes Meet mRNA: Efficient Delivery of Modified mRNA Using Hemocompatible and Stable Vectors for Therapeutic Applications.

Authors:  Tatjana Michel; Daniel Luft; Meike-Kristin Abraham; Sabrina Reinhardt; Martha L Salinas Medina; Julia Kurz; Martin Schaller; Meltem Avci-Adali; Christian Schlensak; Karlheinz Peter; Hans Peter Wendel; Xiaowei Wang; Stefanie Krajewski
Journal:  Mol Ther Nucleic Acids       Date:  2017-07-25       Impact factor: 8.886

6.  De Novo Synthesis of Elastin by Exogenous Delivery of Synthetic Modified mRNA into Skin and Elastin-Deficient Cells.

Authors:  Mario Lescan; Regine Mariette Perl; Sonia Golombek; Martin Pilz; Ludmilla Hann; Mahua Yasmin; Andreas Behring; Timea Keller; Andrea Nolte; Franziska Gruhn; Efrat Kochba; Yotam Levin; Christian Schlensak; Hans Peter Wendel; Meltem Avci-Adali
Journal:  Mol Ther Nucleic Acids       Date:  2018-03-30       Impact factor: 8.886

7.  Intradermal Delivery of Synthetic mRNA Using Hollow Microneedles for Efficient and Rapid Production of Exogenous Proteins in Skin.

Authors:  Sonia Golombek; Martin Pilz; Heidrun Steinle; Efrat Kochba; Yotam Levin; Dominique Lunter; Christian Schlensak; Hans Peter Wendel; Meltem Avci-Adali
Journal:  Mol Ther Nucleic Acids       Date:  2018-03-14       Impact factor: 8.886

8.  Incorporation of Synthetic mRNA in Injectable Chitosan-Alginate Hybrid Hydrogels for Local and Sustained Expression of Exogenous Proteins in Cells.

Authors:  Heidrun Steinle; Tudor-Mihai Ionescu; Selina Schenk; Sonia Golombek; Silju-John Kunnakattu; Melek Tutku Özbek; Christian Schlensak; Hans Peter Wendel; Meltem Avci-Adali
Journal:  Int J Mol Sci       Date:  2018-04-27       Impact factor: 5.923

Review 9.  Advances in mRNA Vaccines for Infectious Diseases.

Authors:  Cuiling Zhang; Giulietta Maruggi; Hu Shan; Junwei Li
Journal:  Front Immunol       Date:  2019-03-27       Impact factor: 7.561

10.  Polymerase-tagged respiratory syncytial virus reveals a dynamic rearrangement of the ribonucleocapsid complex during infection.

Authors:  Emmeline L Blanchard; Molly R Braun; Aaron W Lifland; Barbara Ludeke; Sarah L Noton; Daryll Vanover; Chiara Zurla; Rachel Fearns; Philip J Santangelo
Journal:  PLoS Pathog       Date:  2020-10-08       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.